| Authors: |
Sukali G; Africa Health Research Institute, KwaZulu-Natal, South Africa; Division of Infection and Immunity, University College London, London, UK; The Francis Crick Institute, 1 Midland Road, London NW1 1AT, UK., Anderson M; Africa Health Research Institute, KwaZulu-Natal, South Africa; The Francis Crick Institute, 1 Midland Road, London NW1 1AT, UK., Mohammed KS; The Francis Crick Institute, 1 Midland Road, London NW1 1AT, UK; Division of Biosciences, Faculty of Life Sciences, University College London, London, UK., Biggs P; The Francis Crick Institute, 1 Midland Road, London NW1 1AT, UK., Delphin M; The Francis Crick Institute, 1 Midland Road, London NW1 1AT, UK., Redmond JM; The Chemical Biology Science and Technology Platform, The Francis Crick Institute, 1 Midland Road, London NW1 1AT, UK., Maponga T; Division of Medical Virology, Stellenbosch University and National Health Laboratory Service Tygerberg Business Unit, Cape Town, South Africa., Govender K; Africa Health Research Institute, KwaZulu-Natal, South Africa., Amponsah SK; School of Basic and Biomedical Sciences, University of Health and Allied Sciences, Ghana., Alffenaar JW; School of Pharmacy, Faculty of Medicine and Health, University of Sydney, New South Wales, Australia., Waitt C; Infectious Diseases Institute, Makerere University, Uganda; Department of Women's and Children's Health, University of Liverpool, UK., Iwuji C; Africa Health Research Institute, KwaZulu-Natal, South Africa; Department of Global Health and Infection, University of Sussex and University of Brighton, Falmer, UK., Matthews PC; Division of Infection and Immunity, University College London, London, UK; The Francis Crick Institute, 1 Midland Road, London NW1 1AT, UK; University College London Hospitals NHS Foundation Trust, Euston Road, London, UK. Electronic address: philippa.matthews@crick.ac.uk. |
